Advisors Preferred’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-120
Closed -$33K 274
2019
Q3
$33K Buy
+120
New +$33.4K 0.01% 152
2018
Q4
Sell
-196
Closed -$49K 163
2018
Q3
$49K Buy
+196
New +$47.6K 0.02% 160
2018
Q2
Sell
-458
Closed -$88K 239
2018
Q1
$88K Buy
458
+354
+340% +$65.3K 0.04% 141
2017
Q4
$16K Sell
104
-304
-75% -$47.9K 0.01% 181
2017
Q3
$63K Buy
+408
New +$64.5K 0.04% 142
2015
Q2
Sell
-122
Closed -$9.42K 240
2015
Q1
$9.42K Sell
122
-968
-89% -$75.3K 0.01% 223
2014
Q4
$80.8K Buy
+1,090
New +$76.4K 0.04% 203

Other funds holding IDXX

Advisors Preferred's IDXX Position: Q4 2019 in Review

Advisors Preferred sold out of Idexx Laboratories (IDXX) in Q4 2019, closing a stake of 120 shares — an estimated $33K sold.

Advisors Preferred first reported a position in IDXX in Q4 2014 and held it in 7 quarters. The position peaked at $88K in Q1 2018. 761 funds tracked by Wall St. Rank hold IDXX as of Q4 2019.

  • Advisors Preferred reported no remaining Idexx Laboratories position as of Q4 2019 after selling out during the quarter.
  • Advisors Preferred sold 120 Idexx Laboratories shares in Q4 2019, an estimated $33K.
  • Advisors Preferred first reported a position in Idexx Laboratories in Q4 2014 and held it in 7 quarters.
  • Advisors Preferred's Idexx Laboratories position peaked at $88K in Q1 2018.
  • 761 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2019.

Based on Advisors Preferred's 13F filing for Q4 2019, filed 21 Jan 2020.